The submucosa of the duodenum contains ganglion cells of Meissner’s plexus, lymphatic and vascular structures, and is one of only two sites in the gastrointestinal tract that contains submucosal glands (the other being the esophagus). These Brunner glands are lobular collections of tubuloalveolar glands that are limited to the submucosa of the duodenum; however, up to one third of them can reside within the deep mucosa in the absence of pathology (Fig. 3.13).4 These glands are most concentrated at the gastro–duodenal junction and gradually decrease in number distally (Figs. 3.14 and 3.15). The glands are lined by cells (Fig. 3.16) that contain PAS positive and diastase-resistant neutral mucins, and scattered endocrine cells that secrete somatostatin, gastrin, and peptide YY. Secretions empty into the luminal crypt spaces by way of small ducts. Distally, the jejunum and ileum lack Brunner glands.
The muscularis propria surrounds the submucosa and is composed of an inner circular and outer longitudinal layer of smooth muscle. Between these layers lies the myenteric plexus of Auerbach, a major neural plexus of the enteric nervous system. Externally, the bowel is enveloped by subserosal connective tissue and the mesothelial-derived serosa.
PEARLS & PITFALLS
Distinctive Differences Among Regions of Small Bowel
Duodenum: | Contains submucosal Brunner glands, more abundant proximally Villi range from slender and fingerlike to broad and leaflike. |
Jejunum: | Prominent, tall plicae circulares Villi are uniformly slender and fingerlike. |
Ileum: | Submucosal adipose tissue may be present, especially near the ileocecal valve Shorter and fewer plicae circulares Increased proportion of goblet cells Presence of Peyer patches (abundance of lymphoid aggregates) (Fig. 3.17) |
FAQ: My terminal ileum biopsy shows prominent lymphoid aggregates. How can I be sure I am not missing a sneaky hematolymphoid malignancy?
Answer: You are not alone! Prominent lymphoid aggregates can be especially alarming in the terminal ileum and, thus, are a common source of consultation. The small bowel serves as an essential component of the immune system through its perpetual surveillance of the passing luminal contents. Diligent immunosurveillance is facilitated through specialized epithelial cells (M-cells) that transport luminal antigens to the lymphoid aggregates (designated “Peyer patches” when seen in the terminal ileum). Hyperplastic lymphoid aggregates can be sufficiently large as to be visualized endoscopically and can also serve as intussusception lead points, especially in young children.5,6 The epicenter of lymphoid aggregates is in the mucosa but especially prominent cases can feature extension into the submucosa, raising concerns for a hematolymphoid malignancy. Histologic features reassuring for a benign, reactive process include the presence of germinal centers, tingible body macrophages, and a polymorphous constituent lymphoid population (i.e., a variety of cell sizes represented); however if the focus in question seems at all concerning, a quick immunohistochemical panel may be worthwhile (Figs. 3.19–3.37) (Table 3.1).
PEARLS & PITFALLS
CD43 also highlights plasma cells.
Lymphomas treated with Rituximab (anti-CD20) can be CD20 negative (use PAX5 to confirm B lymphocytes in these cases).
PEARLS & PITFALLS
For those of us who do not routinely evaluate hematopathology specimens, it can be difficult to remember the significance of several of the similarly sounding hematopathology markers, particularly BCL-2, BCL-6, and CD10. If you relate to these challenges, consider this dartboard analogy as a handy learning tool (Figs. 3.18 and 3.19). In the game of darts, a player is awarded more points for landing a dart at the prized center bull’s eye due to the challenging nature of this difficult shot, and fewer points for landing a dart in the periphery of the dart board. In this analogy, imagine the center bull’s eye as a germinal center with the highest points awarded (BCL–6 and CD10). In contrast, the peripheral location outside of the germinal center is awarded fewer points (BCL–2). Importantly, this analogy only works for normal lymphoid aggregates! Follicular lymphoma, for example, is characterized by BCL-2 reactive germinal centers due to the t(14;18) rearrangement of BCL-2 and the immunoglobin heavy chain (IgH). See also Table 3.1.
TABLE 3.1: Quick and Dirty Immunohistochemical Panel for Prominent Lymphoid Aggregates versus Select Hematolymphoid Malignancies
ACUTE DUODENITIS PATTERN
CHECKLIST: Etiologic Considerations for the Acute Duodenitis Pattern (Fig. 3.38)
Peptic Injury (due to excess acid)
Reactive Duodenitis (mild histologic changes)
Peptic Ulcer Disease (marked histologic changes)
Infection
Medication (NSAIDs)
Cigarette Smoking
Zollinger–Ellison Syndrome
Inflammatory Bowel Disease
Infiltrative Processes
Radiation Injury
Ischemia
Vasculitis
The acute duodenitis pattern refers to acute inflammation in the epithelium of the duodenum. This injury pattern is most commonly seen in the setting of peptic injury, infection, and medication injury, but can also be a clue to inflammatory bowel disease (IBD), infiltrative processes, ischemia, radiation injury, and others. Careful attention to the clinical presentation and scrutiny of the surrounding mucosa is critical to arriving at the correct diagnosis. Acute duodenitis can be further classified as “mild,” “moderate,” or “marked” based on the qualitative distribution of the acute inflammation; counting neutrophils is not necessary. For a simple rule of thumb, “mild” includes villitis and cryptitis, “moderate” is indicated by crypt abscesses, and “marked” is indicated by sheets of neutrophils with or without erosion/ulceration. By definition, histologic features of chronic injury are absent, that is, architectural distortion, gastric foveolar metaplasia, and pyloric gland metaplasia are not seen with simple acute duodenitis. When features of chronic damage are established, the injury has occurred over a longer time period and the differential diagnostic considerations expand to include chronic injury of any sort (i.e., chronic peptic injury, chronic infections, chronic medication injury, in addition to IBD and others).
PEPTIC INJURY
Peptic injury describes a broad morphologic range of duodenal injury ranging from spotty acute inflammation to deep, penetrating ulcers. At the mild end of the spectrum, peptic injury manifests with the following histologic features:
1. Increased plasma cell infiltration
2. Neutrophils in the lamina propria or epithelium (or in both) (Figs. 3.39 and 3.40)
3. Reactive epithelial changes including villous blunting
4. Gastric foveolar (mucin cell) metaplasia
This mild injury pattern is interchangeably referred to as “reactive duodenopathy,” “gastric foveolar metaplasia,” “chronic peptic duodenopathy,” “chronic peptic duodenitis” and “peptic-type duodenopathy.” Based on the variable villous blunting, the pattern is more extensively discussed in the Malabsorption Pattern, this chapter. Briefly, this pattern is historically associated with excessive gastric acid production coupled with insufficient protective effects of bicarbonate. Strong links with Helicobacter are not seen in reactive duodenopathy, in contrast to peptic ulcer disease (PUD). PUD represents the extreme range of peptic injury characterized by ulcerations, marked acute and chronic inflammation, mucin attenuation, and reactive changes. PUD is attributable to Helicobacter in the majority of cases, although nonsteroidal anti-inflammatory drugs (NSAIDs) and cigarette smoking are also implicated. Recurrent, multifocal, or marked peptic ulcer disease may serve as an important red flag to Zollinger–Ellison syndrome. Recall that Zollinger–Ellison syndrome is characterized by gastrinoma (and tumor-mediated hypergastrinemia), hyperplasia of the oxyntic compartment, increased gastric acid production, and gastric and small bowel ulcerations. See also Hyperplasia Pattern, Stomach Chapter.
INFECTION
Helicobacter remains a leading contender in infectious agents associated with the acute duodenitis pattern. Its histology can show similar features to the analogous gastric process with brisk acute and chronic inflammation and conspicuous superficial plasma cells (Figs. 3.41–3.46). If not apparent on H&E, a Helicobacter immunostain can be utilized for suspicious cases.7 Not to be missed, adenovirus and CMV are similarly important infectious agents, particularly in immunocompromised patients. The characteristic intranuclear adenovirus inclusions are glassy eosinophilic, and can be highlighted with an adenovirus immunostain (Fig. 3.47). Adenovirus treatment involves lowering immunosuppressive agents, making the distinction from graft versus host disease (GVHD) critical because GVHD therapy requires increased immunosuppressive therapy. See also GVHD, Lymphocytic Pattern, Esophagus Chapter. Similar to CMV infections of other sites, the characteristic inflammatory backdrop shows a prominence of mononuclear inflammation (lymphocytes, macrophages, lymphocytes, and plasma cells), in addition to active background injury and increased apoptotic bodies. The classic CMV viral cytopathic effect includes nuclear enlargement, prominent nuclear inclusions (with an “owl’s eye” appearance), and cytoplasmic inclusions (Figs. 3.48–3.50). In the stomach and small bowel, CMV viral cytopathic changes can be more prominent in the epithelium rather than the stromal and endothelial cells; the latter changes more common in CMV esophagitis, colitis, and proctitis.
KEY FEATURES of the Acute Duodenitis Pattern:
• Acute duodenitis refers to acute inflammation in the epithelium of the duodenum.
• The most common etiologies include peptic injury, infection, and medication injury.
• Reactive duodenopathy shows mild mucosal damage and is due to excess gastric acid; it has no strong association with Helicobacter.
• Peptic ulcer disease is due to Helicobacter in the majority of cases, although NSAIDs and cigarette smoking also play a causal role.
• Helicobacter remains the most common identifiable infectious etiology of the acute duodenitis pattern.
ACUTE ILEITIS PATTERN
Similar to that in the acute duodenitis pattern, acute inflammation in the epithelium of the ileum can qualitatively be scored “mild,” “moderate,” or “marked” based on the relative prominence of acute inflammation in the epithelium (Figs. 3.51–3.55). Comparatively, the acute ileitis pattern is associated with a slightly modified differential diagnostic list of etiologic considerations. In this section, the discussion emphasizes etiologic considerations particularly important to the ileum.
CHECKLIST: Etiologic Considerations for the Acute Ileitis Pattern
Medications (i.e., NSAIDs, ipilimumab, other chemotherapeutic agents)
Infection (CMV, Adenovirus, and Typical Stool Pathogens, including Yersinia, Salmonella, others)
Inflammatory Bowel Disease
Infiltrative Processes (i.e., Amyloidosis or Malignancy)
Radiation Injury
Ischemia
Vasculitis
MEDICATIONS
Medication-related injury constitutes the most common cause of the acute ileitis pattern of injury, particularly in adults. In an endoscopic study of long-term NSAID users, up to 71% showed distal small bowel mucosal injury compared to only 10% of non-NSAID users (p < 0.001).8 NSAIDs mediate injury via nonselective inhibition of cyclooxygenase isoenzymes resulting in decreased production of mucosal protectant products, such as prostaglandins, mucin, and bicarbonate, and dampened microcirculation. The injury pattern can range from mild acute ileitis to erosions, deep-penetrating ulcerations, perforations, and necrosis (Fig. 3.55). The so-called diaphragm disease is a rare but clinically significant consequence seen in up to 2% of patients with chronic NSAID usage and is presumed to be pathognomonic for NSAID-related injury. See also Diaphragm Disease, Chronic Ileitis, this chapter. Although NSAID-related injury can occur at any point along the tubular GI tract, the terminal ileum is particularly vulnerable because of the increased popularity of extended release formulations that delay release of NSAIDs (and the associated mucosal damage) from the stomach to distal bowel segments, including the terminal ileum9 and even the colon.10,11 Other proposed factors include the geographic specific constraints of the terminal ileum; the prominent lymphoid aggregates and narrowed ileocecal valve may result in increased tablet-mucosal contact and related physical and or chemical injury.9
INFLAMMATORY BOWEL DISEASE
The acute ileitis pattern can also herald inflammatory bowel disease (IBD). Although IBD is discussed at length in Inflammatory Bowel Disease, Chronic Colitis, Colon Chapter, a few comments pertaining to the terminal ileum are warranted. Importantly, terminal ileal injury is not restricted to Crohn disease. Up to 17% of ulcerative colitis cases are associated with acute ileitis via a process termed “backwash ileitis.”12 “Backwash ileitis” occurs in a background of marked pancolitis whereby the inflammatory rich luminal contents in the colon are refluxed into the contiguous terminal ileum segment, causing associated inflammatory and reactive changes. The degree of terminal ileum injury is usually mild, or no greater than that in the cecum, and features of chronic mucosal injury are uncommon (Figs. 3.56 and 3.57).12 If terminal ileum restricted injury is present and the adjoining colon shows unremarkable mucosa, medication injury, infection, or Crohn disease would figure a more likely etiology.
When assessing the acute ileitis pattern, it is worthwhile to carefully scrutinize the background mucosa for any additional diagnostic clues that might help refine the diagnosis. For example, aphthoid lesions/ulcers consist of acute inflammation in the epithelium overlying lymphoid aggregates and their presence can lend support to a clinicopathologic diagnosis of Crohn disease (Figs. 3.52–3.54). Although granulomata can be difficult to detect in the normally busy-appearing terminal ileum biopsies, their presence can also be helpful when considering the possibility of Crohn disease, infection, sarcoidosis, or medication injury (Figs. 3.58–3.65). Features of chronic mucosal injury are also important to identify, such as pyloric gland metaplasia and architectural distortion, although these features can be seen with chronic injury of any sort, such as chronic NSAID-associated injury or chronic infections (Figs. 3.58–3.73). Histologic features of chronic mucosal injury are extensively discussed in Chronic Colitis, Colon Chapter. Based on the overlapping features between IBD, chronic medication injury, and chronic infection, IBD is remains a clinicopathologic diagnosis that must encompass all available clinicopathologic features (clinical symptomatology, disease course, disease distribution pattern, pertinent microbiologic studies, and family history, etc.).13
KEY FEATURES of the Acute Ileitis Pattern:
• Medication-related injury constitutes the most common etiology, followed by infection and IBD (Crohn disease > ulcerative colitis).
• This injury pattern ranges from mild acute ileitis to erosions, deep-penetrating ulcerations, perforations, and necrosis.
• Diaphragm disease is a rare consequence of chronic NSAID usage and refers to mucosal strictures that concentrically involve the bowel wall, narrowing the lumen to a pinhole size, resulting in obstruction.
• Assess the background mucosa for clues such as aphthoid lesions, granulomata, features of chronic mucosal injury, radiation injury, amyloidosis, and neoplasia, in attempts to uncover the etiology.
CHRONIC INFLAMMATION PATTERN
CHECKLIST: Etiologic Considerations for the Chronic Inflammation Pattern
Reactive Duodenopathy
Inflammatory Bowel Disease
Infection
Inflammatory or Immune-Regulated Disorders (i.e., Psoriasis)
The chronic inflammation pattern is defined by mild expansion of the lamina propria with mononuclear cells or lymphoid aggregates in the absence of villous blunting or intraepithelial lymphocytosis (Fig. 3.74). This is the most nonspecific of the small bowel patterns, but also among the most common. Etiologic considerations include reactive duodenopathy (see Malabsorption Pattern, this chapter), infection, and upper tract involvement by IBD (Figs. 3.75 and 3.76). Up to 40% of patients with Crohn disease may show active, chronic, and granulomatous inflammation in varying proportions.14 By comparison, ulcerative colitis is typically limited to the lower gastrointestinal tract, although up to 10% of ulcerative colitis patients may demonstrate a diffuse chronic duodenitis.15 Keep in mind, however, that IBD is a primary consideration only when the changes are “focally enhanced” (Figs. 3.77 and 3.78) (See Focally Enhanced Gastritis, Stomach Chapter) or are accompanied by mucosal granulomata, or if lower gastrointestinal tract disease is present. Sampling error in the duodenum may result in the lack of specific features, and this can raise a host of other differential diagnoses, such as medication-induced changes, upstream gastric disease, and other inflammatory or immune-regulated disorders. One such example is psoriasis, which may show mild duodenal inflammation and mast cell infiltration.16–18 It is perhaps, therefore, best not to speculate on the etiology of a mild nonspecific duodenitis in the absence of clinical information. Rather, simple documentation of the mild abnormality and acknowledgement of pertinent negatives are sufficient.
SAMPLE NOTE: SMALL BOWEL WITH MILD CHRONIC INFLAMMATION, BUT NO OTHER SPECIFIC FEATURES:
Small Bowel, Biopsy:
• Small intestinal mucosa with mildly increased lamina propria chronic inflammation, nonspecific.
• Negative for intraepithelial lymphocytosis or villous blunting.
CRYPT ARCHITECTURAL DISTURBANCE PATTERN
CHECKLIST: Etiologic Considerations for the Architectural Disturbance Pattern
Inflammatory Bowel Disease
Diaphragm Disease
Ischemia
Graft Versus Host Disease
Acute Medication Reaction (Mycophenolate Mofetil and Mycophenolic Acid)
Allograft Rejection
Radiation Duodenitis
Pouchitis and Pouch-Related Changes
At scanning magnification, the appearance of crypt architectural disturbance can be seen as: crypt distortion, crypt dropout, crypt shortfall with or without basal lymphoplasmacytosis, or microcrypt formation (Fig. 3.79). Note that this pattern is exclusive of villous architectural changes (i.e., villous blunting), which, instead, is a feature of malabsorption pattern and confers a different group of differential diagnoses. Although some might consider villous blunting a feature of chronic injury, isolated architectural disturbances of the villi should be investigated as a malabsorption pattern. Furthermore, although many of these features indicate chronic injury, this pattern spans a histologic spectrum from subtle to striking, encompassing features from the earliest crypt disturbance (a single withered crypt) to marked crypt distortion. Crypt architectural disturbance is a nonspecific pattern of injury, the etiology of which encompasses IBD, mesenteric ischemia, graft versus host disease, allograft rejection, short gut syndrome, radiation duodenitis, and (ileal) pouchitis. Incisive readers will note that crypt disturbances are a minor histologic pattern in many of these entities, and indicate chronic injury. Accordingly, examination for other primary features (e.g., increased apoptotic bodies in graft vs. host disease) and correlation with clinical circumstances are required to arrive at an etiology.
INFLAMMATORY BOWEL DISEASE
Crohn disease is a chronic idiopathic inflammatory disorder characteristically involving the distal 15 to 25 cm of the terminal ileum; however the gastrointestinal manifestations of Crohn disease are remarkably diverse and may include variations such as ileocolic Crohn disease (30% to 50% of patients with Crohn disease), localized or extensive disease of the small bowel (25% to 50%), isolated Crohn colitis (15% to 30%), anorectal Crohn disease (5% to 19%), or gastric, esophageal and duodenal Crohn disease (5% to 30%).19–22 Histologically, the disease manifests in a patchy distribution with a combination of activity (cryptitis, crypt abscess, erosion, and ulceration) and chronicity (villous blunting, crypt architectural distortion, crypt dropout, crypt shortfall, basal lymphoplasmacytosis, increased lamina propria chronic inflammation, pyloric metaplasia, transmural lymphoid aggregates, and neuromuscular hyperplasia&emdash;with or without granulomata). For an expanded discussion on the general features of Crohn disease, see also Inflammatory Bowel Disease, Chronic Colitis Pattern, Colon Chapter.
In the duodenum, Crohn disease produces typical lesions in approximately 0.5% to 4% of patients.23 These lesions usually coexist with ileal involvement, and may extend proximally and distally to involve the stomach or jejunum. By comparison, “regional jejunitis” rarely coexists with duodenal disease and may locally or diffusely involve the jejunum. Progressive transmural inflammation with scarring and deep ulceration may ultimately lead to symptoms associated with intestinal obstruction, perforation, bleeding, or fistula formation. When obstruction develops, it usually does so in the distal ileum, and deep linear ulcers or fistulae may give rise to profound gastrointestinal bleeding. Gross and full-thickness microscopic examination of the small bowel are considered the gold standard for diagnosis. Gross pathology shows thickening of the bowel wall, fistula formation, strictures, serpiginous ulcers, aphthous ulcers, and creeping mesenteric fat. The corresponding histology shows a combination of variable activity (cryptitis, villitis, crypt abscess, erosion, and ulcer) and chronicity (villous blunting, crypt architectural distortion, crypt dropout, crypt shortfall, basal lymphoplasmacytosis, increased lamina propria chronic inflammation, pyloric metaplasia, transmural lymphoid aggregates, and neuromuscular hyperplasia&emdash;with or without granulomata) (Figs. 3.80–3.87).
FAQ: What is “creeping fat?”
Answer: The antimesenteric serosal surface of the small bowel and colon is usually smooth and devoid of adipose tissue. In Crohn disease, repeated cycles of transmural damage can result in an irregular antimesenteric serosal surface composed of prominent fibrosis and fat (“creeping fat”). This creeping fat is used by surgeons to identify the extent of affected bowel for resection. In addition, this finding should be documented at the grossing bench as it can help differentiate Crohn disease from ulcerative colitis.
FAQ: Does involvement of resection margins by Crohn disease have prognostic significance?
Answer: No.
The status of resection margins is not predictive of disease recurrence.24 Postoperative recurrence of Crohn disease is more common in patients with greater disease extent, perforating disease, and medically refractory Crohn disease.25
DIAPHRAGM DISEASE
NSAIDs cause a wide spectrum of histologic changes in the small bowel, some of which are segment specific, such as diaphragm disease of the terminal ileum. Mild lesions consist of superficial erosions with nonspecific neutrophilic, eosinophilic and plasmacytic infiltrates. These erosions may be multiple, can coalesce forming deep ulcers, and may result in hemorrhage. Repeat cycles of ulceration and healing can cause submucosal scarring and web-like mucosal septa that project into the lumen. These resulting circumferential stenosing lesions appear as multiple diaphragm-like narrowings and are more commonly seen in the distal small bowel, particularly the terminal ileum (Figs. 3.88 and 3.89). Accordingly, the patients often present with a surgically emergent obstruction. This so-called diaphragm disease can be accompanied by a wide array of additional abnormalities, including crypt architectural disturbances mimicking IBD, eosinophilic enteritis, enteritis cystica profunda, and neuromuscular and vascular hamartoma-like changes (Figs. 3.90–3.92).26 By comparison, NSAID injury in the proximal small bowel often results in subtle and nonspecific reactive duodenopathy-type changes, rather than chronic architectural changes. See also Malabsorption Pattern, this chapter. A diagnosis of diaphragm disease can be suggested by the endoscopic or pathologic findings but requires correlation with the patient’s medication list for definitive diagnosis. Distinction from ileal Crohn disease can be particularly challenging if a history of NSAID use cannot be documented; in general, there is minimal chronic inflammation in NSAID-associated injury, whereas it is abundant in Crohn enteritis. Anecdotally, we have seen surreptitious NSAID abuse lead to segmental resection of obstructing diaphragms; family members of the patients may be able to provide the clinical correlation in these cases.